
GC39750
JCN037
Also known as N-(3-bromo-2-fluorophenyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine
JCN037 (JGK037) is non-covalent and BBB-penetrant EGFR tyrosine kinase inhibitor, with IC50 values of 2·49 nM, 3·95 nM, 4·48 nM for EGFR, p-wtEGFR and pEGFRvⅢ, respectively
ChemicalCAS2305154-31-6MW376.18FormulaC16H11BrFN3O2
- CAS number
- 2305154-31-6
- Molecular weight
- 376.18
- Formula
- C16H11BrFN3O2
- Solubility
- DMSO: 250 mg/mL (664·58 mM)
- InChIKey
- MTLUFWWVOINWEL-UHFFFAOYSA-N
- Catalogue number
- GC39750
- Brand
- GLPBIO
Computed properties PubChem CID 138513760 · XLogP 3.9 · TPSA 56.3 Ų · H-bond donors 1
- XLogP
- 3.9
- TPSA
- 56.3 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 2
- Heavy atoms
- 23
SMILES C1COC2=C(O1)C=C3C(=C2)N=CN=C3NC4=C(C(=CC=C4)Br)F
Computed descriptors from PubChem (CID 138513760), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il